Pharma News

Comfortably Numb Device arrest Pain of Drug Injections

  • Posted on: 22 April 2015
  • By: admin

A team of three engineering students from Rice University, Houston, United States, created the device to ease the pain of an injection. A new drug injector called "Comfortably Numb" is a cooling device. It numbs the skin prior to getting a shot.  It works like an ice pack, which produces a rapid chemical reaction that cools and numbs patients' skin in seconds. The device consists of a small 3D-printed cylinder with a metal plate at one end. It contain ammonium nitrate and water in separate compartments.

Aeterna Zentaris plans to conduct phase 3 study of Macrilen in AGHD

  • Posted on: 22 April 2015
  • By: admin

Aeterna Zentaris Inc., a specialty biopharmaceutical company, is planning to conduct a new, confirmatory phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency (AGHD), as well as a dedicated thorough QT study to evaluate the effect of Macrilen on myocardial repolarisation.

Exelixis’ cabozantinib received Fast Track designation by US FDA for RCC treatment

  • Posted on: 17 April 2015
  • By: PharmaTutor News

The US Food & Drug Administration (FDA) has granted Fast Track designation to Exelixis, Inc's cabozantinib for treatment of patients with advanced renal cell carcinoma (RCC). Cabozantinib is the Exelixis' lead compound . Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.

Pharma sector to soon showcase new drugs: Vardhan

  • Posted on: 16 April 2015
  • By: PharmaTutor News

The Indian pharmaceutical sector would soon be showcasing new drugs for malaria, osteoporosis and diabetes, Union Minister for Science and Technology Harsh Vardhan said. These drugs are currently undergoing clinical trials, he said.

 

Sun Pharma, Israel university ink pact to develop anti-cancer drugs

  • Posted on: 16 April 2015
  • By: PharmaTutor News

Sun Pharmaceutical Industries has inked a pact with Israel's Technion university to develop anti-cancer drugs. The subsidiaries of the Mumbai-based drug firm and Technion - Israel Institute of Technology have entered into an exclusive worldwide research and license agreement, Sun Pharma said in a statement.

Gum disease treatment is linked with preventing Heart Disease

  • Posted on: 15 April 2015
  • By: PharmaTutor News

A new study from the Forsyth Institute is helping to shed more light on the important connection between the mouth and heart. According to research recently published online by the American Heart Association, scientists at Forsyth and Boston University have demonstrated that using an oral topical remedy to reduce inflammation associated with periodontitis, more commonly known as gum disease, also results in the prevention of vascular inflammation and can lower the risk of heart attack.

Pages